These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31125381)

  • 21. The role of cytochrome P450 BM3 phenylalanine-87 and threonine-268 in binding organic hydroperoxides.
    Roberts AG; Katayama J; Kaspera R; Ledwitch KV; Le Trong I; Stenkamp RE; Thompson JA; Totah RA
    Biochim Biophys Acta; 2016 Apr; 1860(4):669-77. PubMed ID: 26723172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
    Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
    J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer.
    Ivanov YD; Taldaev A; Lisitsa AV; Ponomarenko EA; Archakov AI
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
    Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
    Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
    Yuan X; Wang Q; Horner JH; Sheng X; Newcomb M
    Biochemistry; 2009 Sep; 48(38):9140-6. PubMed ID: 19708688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
    Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
    ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.
    Chen CK; Berry RE; Shokhireva TKh; Murataliev MB; Zhang H; Walker FA
    J Biol Inorg Chem; 2010 Feb; 15(2):159-74. PubMed ID: 19727859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
    Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
    Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3.
    Butler CF; Peet C; McLean KJ; Baynham MT; Blankley RT; Fisher K; Rigby SE; Leys D; Voice MW; Munro AW
    Biochem J; 2014 Jun; 460(2):247-59. PubMed ID: 24588219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising properties of cytochrome P450 BM3 reconstituted from separate domains by split intein.
    Yoo SK; Cheong DE; Yoo HS; Choi HJ; Nguyen NA; Yun CH; Kim GJ
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132793. PubMed ID: 38830492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space.
    Reinen J; van Leeuwen JS; Li Y; Sun L; Grootenhuis PD; Decker CJ; Saunders J; Vermeulen NP; Commandeur JN
    Drug Metab Dispos; 2011 Sep; 39(9):1568-76. PubMed ID: 21673132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P450(BM3) (CYP102A1): connecting the dots.
    Whitehouse CJ; Bell SG; Wong LL
    Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Dynamics and QM/MM Calculations Predict the Substrate-Induced Gating of Cytochrome P450 BM3 and the Regio- and Stereoselectivity of Fatty Acid Hydroxylation.
    Dubey KD; Wang B; Shaik S
    J Am Chem Soc; 2016 Jan; 138(3):837-45. PubMed ID: 26716578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches.
    Jeffreys LN; Pacholarz KJ; Johannissen LO; Girvan HM; Barran PE; Voice MW; Munro AW
    J Biol Chem; 2020 May; 295(22):7595-7607. PubMed ID: 32303637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural rationalization of novel drug metabolizing mutants of cytochrome P450 BM3.
    Stjernschantz E; van Vugt-Lussenburg BM; Bonifacio A; de Beer SB; van der Zwan G; Gooijer C; Commandeur JN; Vermeulen NP; Oostenbrink C
    Proteins; 2008 Apr; 71(1):336-52. PubMed ID: 17957765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
    Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
    Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.
    Geronimo I; Denning CA; Rogers WE; Othman T; Huxford T; Heidary DK; Glazer EC; Payne CM
    Biochemistry; 2016 Jun; 55(25):3594-606. PubMed ID: 27267136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein and electrode engineering for the covalent immobilization of P450 BMP on gold.
    Ferrero VE; Andolfi L; Di Nardo G; Sadeghi SJ; Fantuzzi A; Cannistraro S; Gilardi G
    Anal Chem; 2008 Nov; 80(22):8438-46. PubMed ID: 18947200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.